RecruitingNot ApplicableNCT06435052

Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan

Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan: A Full-fledged Randomized Controlled Trial


Sponsor

Khushal Khan Khattak Univeristy, Karak, Pakistan

Enrollment

200 participants

Start Date

Aug 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization \& Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria1

  • reverse of the exclusion critera

Exclusion Criteria6

  • The following patients will be excluded:
  • Patients below the age of 15 years and above 60 years, since this study is neither on children nor on old aged patients;
  • Patients who can't move their hands and eyes/or can't perform basic movements;
  • Patients who are unconscious for longer periods and unable to recover consciousness;
  • Patients not meeting the basic screening criteria of PTSD/ PTSD is not the main problem;
  • Patients with severe intellectual impairments, since such patients are difficult to communicate

Interventions

BEHAVIORALEye Movement Desensitization & Reprocessing Therapy

Eye Movement Desensitization and Reprocessing (EMDR) therapy will be administered face-to-face by a psychotherapist in a total of 12 sessions, with one session per week. The efficacy of EMDR therapy will be compared with Cognitive Behavioral Therapy in the treatment of Post-Traumatic Stress Disorder in Pakistan.

BEHAVIORALCognitive Behavioral Therapy

Cognitive Behavioral Therapy will be comparatively checked with Eye Movement Desensitization \& Reprocessing Therapy for its efficacy. It will be administered by psychotherapist in 14 sessions (each session per week)


Locations(1)

Anwar Khan

Karak, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06435052


Related Trials